.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Express Scripts
Daiichi Sankyo
UBS
Harvard Business School
US Department of Justice
Farmers Insurance
Queensland Health
Colorcon
Boehringer Ingelheim

Generated: December 17, 2017

DrugPatentWatch Database Preview

Details for Patent: ► Subscribe

« Back to Dashboard

Details for Patent: ► Subscribe

Title:Carboxylic acid derivatives, their preparation and their use
Abstract: A compound of the formula ##STR00001## pharmaceutically acceptable salts and enantiomers thereof and pharmaceutical compositions containing this compound, its pharmaceutically acceptable salts and enantiomers are claimed.
Inventor(s): Riechers; Hartmut (Neustadt, DE), Klinge; Dagmar (Heidelberg, DE), Amberg; Wilhelm (Friedrichsdorf, DE), Kling; Andreas (Mannheim, DE), Muller; Stefan (Speyer, DE), Baumann; Ernst (Dudenhofen, DE), Rheinheimer; Joachim (Ludwigshafen, DE), Vogelbacher; Uwe Josef (Ludwigshafen, DE), Wernet; Wolfgang (Hassloch, DE), Unger; Liliane (Ludwigshafen, DE), Raschack; Manfred (Weisenheim, DE)
Assignee: Abbott GmbH & Co. KG (Wiesbaden, DE)
Filing Date:Mar 16, 2006
Application Number:11/377,879
Claims:1. The compound ##STR00016##

2. A compound of the formula: ##STR00017## wherein: X is CH; Y is oxygen; Z is oxygen; R is CO.sub.2H; R.sub.2 is methoxy; R.sub.3 is methoxy; R.sub.4 is phenyl; R.sub.5 is phenyl; R.sub.6 is methyl, or a pharmaceutically acceptable salt thereof.

3. The compound of claim 2, wherein said compound is an optically active enantiomer.

4. The compound of claim 3, wherein the enantiomer is the S enantiomer.

5. The compound of claim 4, wherein the enantiomer is the pure form of the S enantiomer.

6. The compound of claim 3, wherein the enantiomer is the R enantiomer.

7. The compound of claim 6, wherein the enantiomer is the pure form of the R enantiomer.

8. A pharmaceutical composition comprising a compound having the formula: ##STR00018## wherein: X is CH; Y is oxygen; Z is oxygen; R is CO.sub.2H; R.sup.2 is methoxy; R.sub.3 is methoxy; R.sub.4 is phenyl; R.sub.5 is phenyl; R.sup.6 is methyl; or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier.

9. The composition of claim 8, wherein said composition is suitable for oral, parenteral, or nasopharyngeal delivery.

10. The composition of claim 8, wherein the composition is in a solid form.

11. The composition of claim 8, wherein the composition is in a liquid form.

12. The composition of claim 8, wherein the composition is in the form of a tablet, capsule, powder, granule, suppository, solution, colloid, ointment, cream, vapor or spray.

13. The composition of claim 8, wherein the carrier comprises a tablet binder, filler, preservative, tablet disintegrant, flow regulator, plasticizer, wetting agent, dispersant, emulsifier, solvent, release-slowing agent, antioxidant, or propellant gas.

14. The composition of claim 8, wherein the compound is an optically active enantiomer.

15. The composition of claim 14, wherein the enantiomer is the S enantiomer.

16. The composition of claim 15, wherein the enantiomer is the pure form of the S enantiomer.

17. The composition of claim 14, wherein the enantiomer is the R enantiomer.

18. The composition of claim 17, wherein the enantiomer is the pure form of the R enantiomer.
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Novartis
Mallinckrodt
Cipla
US Army
Healthtrust
Merck
McKinsey
Cantor Fitzgerald
Teva
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot